· Volume surge · RGC
Regencell Bioscience Holdings Ltd (RGC) weekly slide deepens with volume pressure
The healthcare name is trading with weak trend confirmation after losses broadened across the one-, four- and twelve-week windows.
Regencell Bioscience Holdings Ltd (RGC) closed at 12.01 USD in the latest weekly market data, leaving the shares down -36.2% for the week. The chart shows a weekly price path over 52 weeks, so the move reflects weekly context rather than live intraday trading.
The selloff is backed by elevated activity and weak technical readings. Volume reached 891,377 shares, above the 13-week average, while Market Dynamics showed pressure at -1.46 and Relative Strength stood at -52.1.